Literature DB >> 2318972

Hydroxyeicosatetraenoic acid metabolism in cultured human skin fibroblasts. Evidence for peroxisomal beta-oxidation.

J A Gordon1, P H Figard, A A Spector.   

Abstract

To determine whether the peroxisome is responsible for hydroxyeicosatetraenoic acid (HETE) oxidation, 12- and 15-HETE oxidation was measured in normal and peroxisomal deficient skin fibroblasts from patients with Zellweger's (cerebrohepatorenal) syndrome. When incubated for 1 h with normal fibroblasts, reverse phase HPLC indicated that 24% of the 12-HETE radioactivity was converted to one major polar metabolite. Chemical derivatization followed by reverse phase HPLC and TLC indicated that this metabolite is 8-hydroxyhexadecatrienoic acid [16:3(8-OH)]. Similarly, 33% of the added 15-HETE was also converted to a more polar metabolite. Neither 12- nor 15-HETE were converted to any metabolites by the peroxisomal deficient (Zellweger) cells. No defect in HETE oxidation was found in other human fibroblast cell lines with diverse metabolic abnormalities. Zellweger fibroblasts accumulated increased amounts of 12-HETE, compared with normal fibroblasts. As in the normal cells, most of the 12-HETE incorporated into Zellweger fibroblasts was present in the choline and ethanolamine phosphoglycerides. Protein synthesis, lysosomal acid lipase activity, and mitochondrial butyrate oxidation were not impaired in the Zellweger fibroblasts. Since the Zellweger cells do not convert 12- and 15-HETE to oxidative metabolites, peroxisomes appear to be the cellular organelle responsible for HETE oxidation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318972      PMCID: PMC296549          DOI: 10.1172/JCI114550

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

Review 1.  Hydroxyeicosatetraenoic acids (HETEs).

Authors:  A A Spector; J A Gordon; S A Moore
Journal:  Prog Lipid Res       Date:  1988       Impact factor: 16.195

2.  Studies on microperoxisomes. V. Are microperoxisomes ubiquitous in mammalian cells?

Authors:  A B Novikoff; P M Novikoff; C Davis; N Quintana
Journal:  J Histochem Cytochem       Date:  1973-08       Impact factor: 2.479

3.  Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome.

Authors:  S Goldfischer; C L Moore; A B Johnson; A J Spiro; M P Valsamis; H K Wisniewski; R H Ritch; W T Norton; I Rapin; L M Gartner
Journal:  Science       Date:  1973-10-05       Impact factor: 47.728

4.  Microbodies: constituent organelles of animal cells.

Authors:  Z Hruban; E L Vigil; A Slesers; E Hopkins
Journal:  Lab Invest       Date:  1972-08       Impact factor: 5.662

5.  A simple, rapid, and sensitive DNA assay procedure.

Authors:  C Labarca; K Paigen
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

6.  Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid.

Authors:  J Y Vanderhoek; R W Bryant; J M Bailey
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

7.  Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.

Authors:  E J Goetzl; J M Woods; R R Gorman
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

8.  Transformation of arachidonic acid into monohydroxy-eicosatetraenoic acids by mouse peritoneal macrophages.

Authors:  H Rabinovitch; J Durand; M Rigaud; F Mendy; J C Breton
Journal:  Lipids       Date:  1981-07       Impact factor: 1.880

9.  14C-labeled substrate catabolism by human diploid fibroblasts derived from infants and adults.

Authors:  W J Rhead; A Moon; V Roettger; K Henkle
Journal:  Biochem Med       Date:  1985-10

10.  Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.

Authors:  M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

View more
  9 in total

1.  Lipoxygenase metabolites in amniotic fluid of patients with Zellweger syndrome.

Authors:  E Mayatepek; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

2.  Defective oxidation of hydroxyeicosatetraenoic acids in the liver of patients with Zellweger syndrome.

Authors:  E Mayatepek; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 3.  Conjugated linoleic acids (CLA) as precursors of a distinct family of PUFA.

Authors:  Sebastiano Banni; Anna Petroni; Milena Blasevich; Gianfranca Carta; Lina Cordeddu; Elisabetta Murru; Maria Paola Melis; Anne Mahon; Martha A Belury
Journal:  Lipids       Date:  2004-11       Impact factor: 1.880

4.  Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts.

Authors:  R J Wanders; S Denis; J P Ruiter; R B Schutgens; C W van Roermund; B S Jacobs
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Attenuated prostaglandin formation in peroxisomal-deficient human skin fibroblasts.

Authors:  J A Gordon; L J Warnock; A A Spector
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Physiological response to lipid peroxidation in ischemia and reperfusion during carotid endarterectomy.

Authors:  Sebastiano Banni; Roberto Montisci; Roberto Sanfilippo; Gabriele Finco; Daniela Sanna; Elena Giordano; Elisabetta Murru; Lina Cordeddu; Gianfranca Carta; Donata Banni; Antonio Marchi
Journal:  Lipids Health Dis       Date:  2010-04-21       Impact factor: 3.876

Review 7.  Emerging targets in lipid-based therapy.

Authors:  Stephanie C Tucker; Kenneth V Honn
Journal:  Biochem Pharmacol       Date:  2012-12-20       Impact factor: 5.858

8.  Deactivation of 12(S)-HETE through (ω-1)-hydroxylation and β-oxidation in alternatively activated macrophages.

Authors:  Tamas Kriska; Michael J Thomas; John R Falck; William B Campbell
Journal:  J Lipid Res       Date:  2018-02-22       Impact factor: 5.922

9.  Oxylipin metabolism is controlled by mitochondrial β-oxidation during bacterial inflammation.

Authors:  Konstantinos Kotzamanis; Luke C Davies; Mariya Misheva; Victoria J Tyrrell; Patricia R S Rodrigues; Gloria A Benavides; Christine Hinz; Robert C Murphy; Paul Kennedy; Philip R Taylor; Marcela Rosas; Simon A Jones; James E McLaren; Sumukh Deshpande; Robert Andrews; Nils Helge Schebb; Magdalena A Czubala; Mark Gurney; Maceler Aldrovandi; Sven W Meckelmann; Peter Ghazal; Victor Darley-Usmar; Daniel A White; Valerie B O'Donnell
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.